These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose. Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323 [TBL] [Abstract][Full Text] [Related]
7. Tolerance of intravenously administered ciprofloxacin. Thorsteinsson SB; Bergan T; Rohwedder R Chemotherapy; 1988; 34(3):256-60. PubMed ID: 3416662 [TBL] [Abstract][Full Text] [Related]
8. Bilateral hydronephrosis from ciprofloxacin induced crystalluria and stone formation. Chopra N; Fine PL; Price B; Atlas I J Urol; 2000 Aug; 164(2):438. PubMed ID: 10893604 [No Abstract] [Full Text] [Related]
9. Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review. Dichiara AJ; Atkinson M; Goodman Z; Sherman KE Minerva Gastroenterol Dietol; 2008 Sep; 54(3):307-15. PubMed ID: 18614979 [TBL] [Abstract][Full Text] [Related]
10. [Fluoroquinolone induced acute renal failure. General review about a case report with crystalluria due to ciprofloxacin]. Montagnac R; Briat C; Schillinger F; Sartelet H; Birembaut P; Daudon M Nephrol Ther; 2005 Mar; 1(1):44-51. PubMed ID: 16895667 [TBL] [Abstract][Full Text] [Related]
11. Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine. Tzovaras V; Tsimihodimos V; Kostara C; Mitrogianni Z; Elisaf M Nephrol Dial Transplant; 2011 Oct; 26(10):3219-24. PubMed ID: 21372252 [TBL] [Abstract][Full Text] [Related]
12. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study. Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830 [TBL] [Abstract][Full Text] [Related]
13. Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir. Gagnon RF; Tecimer SN; Watters AK; Tsoukas CM Am J Kidney Dis; 2000 Sep; 36(3):507-15. PubMed ID: 10977782 [TBL] [Abstract][Full Text] [Related]
14. Isolation and structural elucidation of urinary metabolites of ciprofloxacin. Gau W; Kurz J; Petersen U; Ploschke HJ; Wuensche C Arzneimittelforschung; 1986 Oct; 36(10):1545-9. PubMed ID: 3814216 [TBL] [Abstract][Full Text] [Related]
16. Identification of Amoxicillin Crystals in Urine: a Case Report. Fanelli A; Rapi S; Dugheri S; Bonari A; Milletti E; Cappelli G; Mucci N; Arcangeli G Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162882 [TBL] [Abstract][Full Text] [Related]
17. Identification and quantification of ciprofloxacin in urine through excitation-emission fluorescence and three-way PARAFAC calibration. Ortiz MC; Sarabia LA; Sánchez MS; Giménez D Anal Chim Acta; 2009 May; 642(1-2):193-205. PubMed ID: 19427476 [TBL] [Abstract][Full Text] [Related]
18. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors. Schwille PO; Wipplinger J Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191 [TBL] [Abstract][Full Text] [Related]
19. [Rhabdomyolysis and acute renal failure secondary to ciprofloxacin therapy]. Khammassi N; Abdelhedi H; Mohsen D; Ben Sassi M; Cherif O Therapie; 2012; 67(1):67-8. PubMed ID: 22487506 [No Abstract] [Full Text] [Related]
20. Metabolomic studies of patient material by high-resolution magic angle spinning nuclear magnetic resonance spectroscopy. Keun H Methods Enzymol; 2014; 543():297-313. PubMed ID: 24924139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]